BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17696930)

  • 1. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
    Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
    Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative transporter pathways in patients with untreated early-stage and late-stage primary biliary cirrhosis.
    Takeyama Y; Uehara Y; Inomata S; Morihara D; Nishizawa S; Ueda S; Matsumoto T; Tanaka T; Anan A; Nishimura H; Irie M; Iwata K; Shakado S; Sohda T; Sakisaka S
    Liver Int; 2009 Mar; 29(3):406-14. PubMed ID: 18662272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction.
    Chai J; Feng X; Zhang L; Chen S; Cheng Y; He X; Yang Y; He Y; Wang H; Wang R; Chen W
    PLoS One; 2015; 10(3):e0120055. PubMed ID: 25798860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
    Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
    Wang L; Wu G; Wu F; Jiang N; Lin Y
    J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.
    Wunsch E; Milkiewicz M; Wasik U; Trottier J; Kempińska-Podhorodecka A; Elias E; Barbier O; Milkiewicz P
    Sci Rep; 2015 Aug; 5():13462. PubMed ID: 26293907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.
    Feng XC; Du X; Chen S; Yue D; Cheng Y; Zhang L; Gao Y; Li S; Chen L; Peng Z; Yang Y; Luo W; Wang R; Chen W; Chai J
    Int J Clin Exp Pathol; 2015; 8(1):184-95. PubMed ID: 25755705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.
    Barrett KG; Fang H; Cukovic D; Dombkowski AA; Kocarek TA; Runge-Morris M
    Drug Metab Dispos; 2015 Jul; 43(7):1061-70. PubMed ID: 25948711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.
    Kolouchova G; Brcakova E; Hirsova P; Sispera L; Tomsik P; Cermanova J; Hyspler R; Slanarova M; Fuksa L; Lotkova H; Micuda S
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1544-51. PubMed ID: 21501227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia.
    Chen HL; Liu YJ; Chen HL; Wu SH; Ni YH; Ho MC; Lai HS; Hsu WM; Hsu HY; Tseng HC; Jeng YM; Chang MH
    Pediatr Res; 2008 Jun; 63(6):667-73. PubMed ID: 18327154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
    Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
    Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
    Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P
    J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver.
    Rosales R; Romero MR; Vaquero J; Monte MJ; Requena P; Martinez-Augustin O; Sanchez de Medina F; Marin JJ
    Biochem Pharmacol; 2013 Mar; 85(6):829-38. PubMed ID: 23313557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices.
    Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
    Toxicol In Vitro; 2011 Feb; 25(1):80-90. PubMed ID: 20888898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.